“Incorporating the 40-Gene Expression Profile (40-GEP) Test for Poorly Differentiated Cutaneous Squamous Cell Carcinoma (cSCC) Tumors Mitigates Risk Assessment Uncertainty from Histologic Grading”. SKIN The Journal of Cutaneous Medicine 7, no. 2 (March 13, 2023): s164. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/2019.